# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025, Regulation 13: Amendment to regulation 13

Extent: E+W+S+N.I.

(1) Regulation 13 (supply of investigational medicinal products for the purpose of clinical trials) is amended as follows.
(2) In paragraph (1)(d), for “subject” substitute “participant”.
(3) In paragraph (2)(b)(ii)—
(a) in sub-paragraph (aa), for “Article 13 of the Directive” substitute “Article 62 of the EU Regulation”;
(b) in sub-paragraph (bb), for “Article 13(3) and (4) of the Directive” substitute “Article 62 of the EU Regulation”.

---
Source: https://www.legislation.gov.uk/uksi/2025/538/regulation/13 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-regulations-2025/regulation-13/enacted
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.